PITTSBURGH, November 24th, 2014 — Gateway Analytical announced today that they will be presenting on the characterization of particulate in inhalable drug products, in addition to exhibiting at the upcoming Drug Delivery to the Lungs (DDL25) in Edinburgh, Scotland, December 10th – 12th.
The focus of DDL25, is to provide a conference dedicated to the continued advancement of formulation development and manufacturing for nasal and inhalation drug products, such as metered-dose and dry powder inhalers. The poster session titled “Chemically-specific Characterization of Particulate in Inhalable Drug Products using Raman and Laser-induced Breakdown Spectroscopy (Raman/LIBS)”, is a collaboration between Gateway Analytical and the University of Bath. This session will discuss how automated Raman/LIBS analysis was used to investigate a drug product contamination issue, and establish the size and chemical makeup (metallic, organic or inorganic) of the foreign particulates.
In addition to the poster session, Gateway Analytical will be exhibiting at the conference to promote their chemically-specific particle sizing and particulate characterization services that provide critical data and quality testing support for inhalation drug developers. “A common challenge drug developers of nasal and inhalation products often face is the ability completely characterize and understand the particles in their formulation” said David Exline, Senior Vice President at Gateway Analytical. “We provide a total particle characterization solution by providing developers with in-depth characterization of their inhalable drugs, which includes differentiating particles by their chemical make-up, acquiring sizing information for each component, evaluating the degree of drug-specific aggregates, and identifying any unknown particulates, which is especially effective in the analysis of complex combinational products.”
Gateway Analytical is a full service, cGMP compliant, ISO 17025:2005 certified, FDA registered and inspected laboratory with specialized expertise in techniques for chemically specific analysis and particulate contamination identification. For more information on Gateway Analytical services, contact Tracey Safran, Senior Account Manager at email@example.com.
About Gateway Analytical
Based in Gibsonia, Pa., Gateway Analytical, LLC offers analytical testing services to companies in need of high-quality laboratory analysis by providing additional testing resources, specialized capabilities and comprehensive testing. Through conventional and innovative testing methods, the company supplies a number of key services for the pharmaceutical, materials science, medical device and forensic industries including; foreign particulate identification, glass delamination analysis, chemically-specific particle sizing, materials characterization, wear debris testing and trace evidence analysis.
Gateway Analytical is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.
ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company’s proprietary, state-of-the-art imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.
ChemImage’s headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.